265 related articles for article (PubMed ID: 1458161)
1. [The effect of protease tissue inhibitor on the activity of pancreatic proteolytic enzymes in in-vitro experiments].
Egorova EF; Chernoiarova OD; Ryzhkova GI
Eksp Klin Farmakol; 1992; 55(3):39-41. PubMed ID: 1458161
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of commercial polyvalent proteinase inhibitors. Comparative analysis of their effect on kallikreins from different sources and trypsin].
Iarovaia GA; Dotsenko VL; Agapova EI; Stepanian EP
Vopr Med Khim; 1980; 26(6):832-7. PubMed ID: 6161484
[TBL] [Abstract][Full Text] [Related]
3. [Effect of serotonin on secretory and lysosomal enzyme activity in pancreatic tissue and the inhibitory properties of serum].
Chernoiarova OD; Trubitsyna IE
Biull Eksp Biol Med; 1981 Oct; 91(10):417-9. PubMed ID: 6914901
[TBL] [Abstract][Full Text] [Related]
4. Canine pancreatic kallikrein: enzyme isolation and characterization.
Ohnishi N; Ikekita M; Atomi Y; Kizuki K; Moriya H; Kondo K; Yamada H; Tsugita A
Protein Seq Data Anal; 1992; 5(1):1-5. PubMed ID: 1492090
[TBL] [Abstract][Full Text] [Related]
5. [Flavonoids extracted from Ribes nigrum L. and Alchemilla vulgaris L.: 1. In vitro inhibitory activities on elastase, trypsin and chymotrypsin. 2. Angioprotective activities compared in vivo].
Jonadet M; Meunier MT; Villie F; Bastide JP; Lamaison JL
J Pharmacol; 1986; 17(1):21-7. PubMed ID: 3635653
[TBL] [Abstract][Full Text] [Related]
6. Metabolites of Pseudevernia furfuracea (L.) Zopf. and their inhibition potential of proteolytic enzymes.
Proksa B; Adamcová J; Sturdíková M; Fuska J
Pharmazie; 1994 Apr; 49(4):282-3. PubMed ID: 8197230
[TBL] [Abstract][Full Text] [Related]
7. Physiology, pharmacology and pathology of exocrine pancreas enzymes with special reference to proteolytic enzymes.
Werle E; Trautschold I
Anglo Ger Med Rev; 1966 Dec; 3(2):212-26. PubMed ID: 4870573
[No Abstract] [Full Text] [Related]
8. [Effect of trypsin and kallikrein (andecalin) on the activity of proteolytic enzymes and their inhibitors in acute experimental pancreatitis].
Kolenda IuV; Vansovich VE; Vovchuk SV; Levitskiĭ AP
Vopr Med Khim; 1987; 33(5):122-4. PubMed ID: 3318106
[TBL] [Abstract][Full Text] [Related]
9. Relationship between protease activity and a sialoglycopeptide inhibitor isolated from bovine brain.
Sharifi BG; Bascom CC; Fattaey H; Nash S; Johnson TC
J Cell Biochem; 1986; 31(1):41-57. PubMed ID: 3522610
[TBL] [Abstract][Full Text] [Related]
10. [Pancreatic inhibitors of proteolytic enzymes].
Wilimowska-pelc A
Postepy Biochem; 1972; 18(1):85-93. PubMed ID: 4616229
[No Abstract] [Full Text] [Related]
11. [Effect of the endolymphatic administration of protease inhibitors on pancreatic morphofunctional activity in acute experimental pancreatitis].
Penin VA; Petrov VV; Titova GP; Sil'monovich NN; Shepilova ZhI
Farmakol Toksikol; 1982; 45(5):83-7. PubMed ID: 6183145
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil apoptosis induced by proteolytic enzymes.
Trevani AS; Andonegui G; Giordano M; Nociari M; Fontán P; Dran G; Geffner JR
Lab Invest; 1996 Mar; 74(3):711-21. PubMed ID: 8600321
[TBL] [Abstract][Full Text] [Related]
14. [Behavior of the kallikrein inhibitor against enzymes, 3. Behavior of the kallikrein inhibitor from bovine lung against proteases].
Kraut H; Bhargava N
Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1498-9. PubMed ID: 4231141
[No Abstract] [Full Text] [Related]
15. Potential effects of PKC or protease inhibitors on acute pancreatitis-induced tissue injury in rats.
Shi C; Zhao X; Wang X; Zhao L; Andersson R
Vascul Pharmacol; 2007 Jun; 46(6):406-11. PubMed ID: 17347056
[TBL] [Abstract][Full Text] [Related]
16. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
Rinderknecht H; Renner IG; Abramson SB; Carmack C
Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
[TBL] [Abstract][Full Text] [Related]
17. Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity.
Spilberg I; Mandell B; Wochner RD
J Lab Clin Med; 1974 Jan; 83(1):56-63. PubMed ID: 4543439
[No Abstract] [Full Text] [Related]
18. Similarity in active site arrangement of neutral protease from calf thymus chromatin and trypsin.
Kowalska-Loth B; Zieleński J; Toczko K; Chmielewska I
Acta Biochim Pol; 1976; 23(2-3):139-44. PubMed ID: 987680
[TBL] [Abstract][Full Text] [Related]
19. [Protease inhibitors in the pancreas and blood serum: their physiological role].
Loginov AS; Amirov NSh; Chernoiarova LD
Fiziol Zh SSSR Im I M Sechenova; 1982 May; 68(5):692-8. PubMed ID: 6178624
[No Abstract] [Full Text] [Related]
20. [Mode of action of a protease inhibitor on pancreatic enzymes].
Blümel G; Piza F
Wien Klin Wochenschr; 1966 Oct; 78(40):660-5. PubMed ID: 5298341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
